Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07176676

Aromatherapy Treatment With Lavender Essential Oil to Reduce Post-Operative Nausea and Vomiting (PONV)

Evaluation of the Efficacy of an Aromatherapy Treatment With Lavender Essential Oil to Reduce Post-Operative Nausea and Vomiting (PONV): Two-arm, Non-pharmacological, Single-centre, Non-profit, Randomised Controlled Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
128 (estimated)
Sponsor
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the effectiveness of aromatherapy through the use of inhaled Lavender oil in reducing patients' nausea during the post-operative period.

Detailed description

To evaluate the effectiveness of inhaling Lavender Angustifolia essential oil in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative period. Secondary objective * To detect the number of antiemetic administrations in the experimental arm compared to the control arm * To measure the patient satisfaction of patients in the experimental group with the Lavender essential oil aromatherapy intervention at hospital discharge Primary endpoint Reduction of nausea by at least 10% compared to treatment with standard care, as assessed by the NRS (Numerical Rating Scale).

Conditions

Interventions

TypeNameDescription
OTHERLavanda Angustifolia essential oilAdministration of Lavender Angustifolia essential oil by inhalation in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative period.
OTHERUsual CarePatients in the Usual Care group will follow the standard procedure, which consists of administering antiemetics if provided in therapy or reporting to the doctor with a subsequent treatment decision

Timeline

Start date
2022-11-15
Primary completion
2024-12-31
Completion
2025-12-15
First posted
2025-09-16
Last updated
2025-09-16

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07176676. Inclusion in this directory is not an endorsement.